(Philadelphia, PA) - Can H. Ficicioglu, MD, PhD, has been named an Assistant Professor in the Department of Pediatrics, division of Metabolism (biochemical genetics), at the University of Pennsylvania School of Medicine.

Dr. Ficicioglu's research interests include the study of outcomes in expanded newborn screening; enzyme replacement treatment on lysosomal storage diseases; and bone marrow transplantations for inborn errors in metabolism. His research has been published in the Journal of Inherited Metabolic Disease, Turkish Journal of Medical & Biological Research, The Turkish Journal of Pediatrics, Neuropediatrics, the Istanbul Cocuk Klinigi Dergisi and Pediatric Neurology, among others.

In 1985, Dr. Ficicioglu received his MD from the University of Istanbul, Cerrahpasa Medical School, and earned his PhD from the University of Marmara in Turkey in 1996. He performed residencies at New York Medical College (St. Vincent's Medical Center), Albert Einstein Medical College (Montefiore Medical Center), and the University of Istanbul. He completed a clinical fellowship in the division of Genetics and Metabolism at Harvard Medical School, Children's Hospital of Boston.

He is a member of The Society for the Study of Inborn Errors of Metabolism, the European Association for the Study of Diabetes and the American Academy of Pediatrics. He was invited to lecture at the National Metabolism Congress in Izmir, Turkey, on the topic, 'NTBC treatment in Tyrosinemia type 1.' In 1994, Dr. Ficicioglu authored the book, "Diabetes Guide" and in 1993, he co-authored the book, "Advances in Metabolic Diseases".

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.

Share This Page: